Heat Biologics, Inc.
Biotechnology
Healthcare
HTBX
25.14 M shares
NASDAQ US
traded
02 May 2022
listed
yes
open
2.41
52 week high
9.60
high
2.48
52 week low
2.10
low
2.33
growth
-60.00 %
previous Close
2.37
P/E ratio
market cap
58.88 M
div yield
0
usd
Dec 2021
qoq
revenue
-347.96 K
-169.37 %
net incoming
-13.89 M
-86.91 %
eps
-80.00 %
eps surprise
-68.75 %
net profit margin
3992.61 %
5474.00 %
operating incoming
-13.90 M
-91.25 %
net change in cash
171 K
101.25 %
cash on hand
8.05 M
2.18 %
cost of revenue
0.00 %
top top